Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: JEB who wrote (201)	1/11/1999 11:42:00 AM
From: QuietWon	Respond to of 2515

I'm in a similar situation with MSH.to on a buyout - co was being dumped b/c the firm dumping was channging the orientation of the fund - it had nothing to do with MSH.to !!! And now MSH.to has gone from $1 to $2.60 !!! IMCL should go up - that dumping I beleive was finished around Xmas- New Year

To: JEB who wrote (201)	1/11/1999 12:58:00 PM
From: 5,17,37,5,101,...	Read Replies (2) \| Respond to of 2515

Excellent find! Thanks. C225 does look like a winner; I agree and have placed a big bet on Imclone. Jackson

To: JEB who wrote (201)	1/11/1999 2:20:00 PM
From: QuietWon	Read Replies (1) \| Respond to of 2515

Watch for H&Q to initate coverage on some stocks from the conference and as IMCL is speaking there, and a leader in its area, I think there's a chance H&Q could initiate coverage on IMCL hamquist.com

To: JEB who wrote (201)	1/11/1999 5:01:00 PM
From: QuietWon	Read Replies (2) \| Respond to of 2515

This should be very explanatory- diff btween IMCL and Entremed - Entremed couldn't reproduce it's results; IMCL has ! In phase II of C225, all but 1 or 2 patients had 100% shrinkage of tumor ! Entremed couldn't reproduce. Now, IMCL has given those results with it's "business plan" for testing Phase III and waiting for FDA go-ahead to enter Phase III. Phase II tells you if it works, and III is a larger scale. BEING PERMITTED TO ENTER PHASE III is the CRUCIAL PT with any drug and remember 50% of stock's gains come from Phase III until Marketing phase. I believe this one's a winner!